Harvard Bioscience, Inc. President to Speak at Dain Rauscher Wessels Genomics & Life Sciences Conference
HOLLISTON, Mass., May 3 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that David Green, President of Harvard Bioscience, will make a presentation at the Dain Rauscher Wessels Genomics & Life Sciences Conference to be held May 7th and 8th in New York City.
The theme of the conference will be - Biotechnology: "Genes to Drugs".
Mr. Green will be presenting an overview of the Company including its products and the markets they address. He will also present the Company's business model and strategy.
Mr. Green may answer questions concerning business and financial developments and trends, and other business and financial matters affecting the Company. Some responses to questions may contain information that has not previously been disclosed. The event will be simultaneously broadcast over the internet at approximately 2.30 pm on May 7th and can be found at http://www.twst.com/dr3conference.html. Archives will be available for 30 days after the conference through The Wall Street Transcript.
Harvard Bioscience is a global developer, manufacturer and marketer of innovative, enabling tools in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. HBIO sells approximately 10,000 products to thousands of researchers in over 60 countries though its 1,000 page catalog, and through its distributors, the most notable of which is AP Biotech. HBIO has sales and manufacturing operations in the United States, the United Kingdom, and Germany with sales facilities in France and Canada.
SOURCE Harvard Bioscience, Inc.
CONTACT: Jim Warren, CFO, jwarren@harvardbioscience.com, or David Green, President, dgreen@harvardbioscience.com, or Chane Graziano, CEO, cgraziano@harvardbioscience.com, all of Harvard Bioscience, Inc./
Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.